Resistance to Targeted Anti-Cancer Therapeutics

Resistance to Ibritumomab in Lymphoma

Editors: Hosono, Makoto, Chatal, Jean-François (Eds.)

    • This book features chapters written by internationally known experts in the field
    • This book will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects and medical physics that deals with radiation dosimetry
    • This book will provide future prospects for overcoming resistance and enhancing the efficacy of Ibritumomab
see more benefits

Buy this book

eBook 101,14 €
price for Spain (gross)
  • Due: May 22, 2018
  • ISBN 978-3-319-78238-6
  • Digitally watermarked, DRM-free
  • Included format:
  • ebooks can be used on all reading devices
Hardcover 124,79 €
price for Spain (gross)
  • Due: May 22, 2018
  • ISBN 978-3-319-78237-9
  • Free shipping for individuals worldwide
  • The final prices may differ from the prices shown due to specifics of VAT rules
About this book

This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumomab.

About the authors

Makoto Hosono, MD, PhD, is a Professor of Radiology and Nuclear Medicine, Institute of Advanced Clinical Medicine, Kindai University Faculty of Medicine, Japan, and serves as a member of Committee 3, International Commission on Radiological Protection. 


Jean-François Chatal, MD, PhD, is an Emeritus Professor of Nuclear Medicine at the University of Nantes, France. He is one of the international leaders who developed radioimmunotherapy, that is, therapy using radiolabeled anti-tumor antibodies. He created and headed an INSERM  research laboratory and also initiated the installation of a cyclotron institute termed ARRONAX for the production of novel radionuclides for nuclear medicine.

Buy this book

eBook 101,14 €
price for Spain (gross)
  • Due: May 22, 2018
  • ISBN 978-3-319-78238-6
  • Digitally watermarked, DRM-free
  • Included format:
  • ebooks can be used on all reading devices
Hardcover 124,79 €
price for Spain (gross)
  • Due: May 22, 2018
  • ISBN 978-3-319-78237-9
  • Free shipping for individuals worldwide
  • The final prices may differ from the prices shown due to specifics of VAT rules
Loading...

Recommended for you

Loading...

Bibliographic Information

Bibliographic Information
Book Title
Resistance to Ibritumomab in Lymphoma
Editors
  • Makoto Hosono
  • Jean-François Chatal
Series Title
Resistance to Targeted Anti-Cancer Therapeutics
Series Volume
18
Copyright
2018
Publisher
Springer International Publishing
Copyright Holder
Springer International Publishing AG, part of Springer Nature
eBook ISBN
978-3-319-78238-6
DOI
10.1007/978-3-319-78238-6
Hardcover ISBN
978-3-319-78237-9
Series ISSN
2196-5501
Edition Number
1
Number of Pages
XIII, 158
Number of Illustrations and Tables
4 b/w illustrations, 14 illustrations in colour
Topics